Can you get rich off of REITs?

Written by Admin | Last Updated: July 2026

Eliminating or curing retinitis pigmentosa is currently impossible, because it is a group of rare, inherited genetic disorders that cause progressive degeneration of the light-sensitive cells in the retina. While traditional medical science cannot yet reverse or completely remove the underlying genetic mutations driving the condition, significant advancements in gene therapy, bionic retinal implants, stem cell research, and neuroprotective agents offer promising avenues to slow progression and preserve remaining vision. Ophthalmologists and retinal specialists work closely with patients to manage symptoms, recommend specialized low-vision aids, prescribe nutritional supplements under strict supervision, and monitor visual field changes over time to maximize quality of life despite the lack of a permanent cure.

Related FAQs

Yes, Murphy Oil confirmed a significant oil discovery in Vietnam through a successful appraisal well. The discovery at the Golden Sea Lion Field has been confirmed to hold more than 300 million barrels of oil, with potential for further upside.

Medical Properties Trust (MPR) is a specialized real estate investment trust (REIT) focusing on hospital facilities, attracting a complex mix of opinions from equity research analysts.

Most conservative institutional analysts advise against purchasing Medical Properties Trust at this stage, categorizing it as a high-risk distressed asset rather than a stable income play.

Medical Properties Trust has experienced severe profitability contractions under GAAP reporting metrics, largely due to massive impairment charges, non-accrual rental defaults by troubled hospital tenants, and high debt servicing costs resulting f...

Medical Properties Trust is rarely recommended as a sound equity purchase by mainstream financial advisors, as the risks associated with hospital tenant bankruptcies and balance sheet restructuring heavily outweigh potential speculative upside.

Signs of a definitive corporate turnaround for Medical Properties Trust remain mixed and highly contentious among market observers.